Mortality Rate

Mortality rate in insurance is the measure of the number of deaths in a specific population over a particular period. It is a critical factor in determining the risk associated with a life insurance policy and is used to calculate the premiums charged by insurers. Mortality rates can be calculated based on various factors, including age, gender, and health conditions.

Here are some key features of mortality rate in insurance:

• Mortality rate is expressed as the number of deaths per unit of population per unit of time, typically expressed as deaths per 1,000 or 100,000 people per year.

• Mortality rates can be calculated for different age groups and genders, as mortality rates can vary significantly depending on these factors.

• Mortality tables, also known as life tables, are used by insurance companies to calculate premiums based on the probability of death for individuals based on their age, gender, and health status.

• Mortality rates are used to determine the expected loss ratio for a life insurance policy, which is the ratio of claims paid out to the total premiums collected over a specific period.

• Mortality rates can also be used to compare the risk of death between different populations, such as comparing mortality rates between countries or regions.

For example, an insurance company may use mortality rates to calculate the premiums for a life insurance policy. The premiums charged will depend on the age, gender, and health status of the policyholder, as well as other factors such as lifestyle habits and family medical history. By using mortality tables, the insurer can estimate the probability of the policyholder's death and charge an appropriate premium to cover the risk.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.